What Does Cystatin C Measure?
Cystatin C is a protein produced by cells in the kidneys that is released into the bloodstream. It’s a non-enzymatic marker of kidney function and has been widely used as a substitute for creatinine in the assessment of kidney function in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).
What is Cystatin C?
Cystatin C is a glycoprotein that is produced by a large number of cells in the body, including red blood cells, white blood cells, and platelets. It’s divided into two main subunits: C1q and C2. The C1q subunit is responsible for binding to the C1r subunit, which is the activated form of the complement system. The C2 subunit is responsible for binding to C4 and C2q, which are part of the complement system.
Metabolism and Excretion
Cystatin C is metabolized by lipoproteins in the bloodstream, and its levels are often used as an indirect marker of kidney function. When a patient has kidney damage, the kidneys are less efficient at filtering out waste products from the blood, which can lead to an increase in cystatin C levels. Conversely, when a patient has normal kidney function, the kidneys are able to filter out waste products more efficiently, leading to lower cystatin C levels.
Normal and Abnormal Values
In healthy individuals, cystatin C levels are typically in the range of 0.6-1.0 μmol/L. However, in patients with kidney damage, such as those with chronic kidney disease (CKD) or end-stage renal disease (ESRD), cystatin C levels are often significantly elevated, typically above 1.0 μmol/L. This elevation is a reliable marker of renal dysfunction.
Here’s a table summarizing the normal and abnormal ranges for cystatin C levels:
| Normal (0.6-1.0 μmol/L) | Abnormal (≥1.0 μmol/L) | |
|---|---|---|
| Kidney function | Healthy | Patients with CKD/ESRD |
| Muscle wasting | Minimal | Severe muscle wasting |
| Blood clotting | Normal | Normal |
| Liver disease | Normal | Elevated |
Clinical Significance
Cystatin C has been shown to have good diagnostic and prognostic value in patients with CKD and ESRD. It’s non-invasive and does not require blood sampling. Cystatin C levels are also a reliable marker of renal function, as they are less affected by changes in coagulation factor levels or liver function.
Here’s a table summarizing the clinical significance of cystatin C levels:
| Clinical Significance | Prevalence | |
|---|---|---|
| Monitoring CKD | Cystatin C levels are used to monitor CKD progression and response to treatment | High (60-90%) |
| Predicting ESRD | Cystatin C levels are used to predict ESRD | High (80-90%) |
| Monitoring renal replacement therapy | Cystatin C levels are used to monitor the effectiveness of renal replacement therapy | High (70-80%) |
Assessment and Interpretation
Cystatin C levels are typically measured in the plasma using a stable isotope dilution method, such as the iCT measurement method. A corrected cystatin C level (cC3e) is used to estimate the total cystatin C catabolism rate. The corrected cC3e is then used to calculate a cystatin C index (CCI), which is a standardized measure of kidney function.
Limitations and Future Directions
While cystatin C has been shown to be a reliable and useful marker of kidney function, there are some limitations to its use. Cystatin C levels can be influenced by various factors, including age, sex, and ethnicity. Additionally, cystatin C levels can be affected by medications, such as ACE inhibitors, which can cause hypokalemia and reduced cystatin C clearance.
Conclusion
Cystatin C is a non-enzymatic marker of kidney function that has been widely used in the assessment of patients with CKD and ESRD. Its advantages include being a reliable and non-invasive marker of renal function, as well as a useful predictor of progression and response to treatment. While there are some limitations to its use, cystatin C continues to be an important tool in the management of patients with CKD and ESRD.